Flag of the European Union EU Clinical Trials Register Help

Clinical trials for Strabismus

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

  • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).


    The EU Clinical Trials Register currently displays   44343   clinical trials with a EudraCT protocol, of which   7372   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    Query did not match any clinical trials.
    These are paediatric studies completed by 26 January 2007, in respect of products authorised in the Community (Article 45 of the Paediatric Regulation (EC) No 1901/2006).
    Note: Advanced search filters for country, trial phase, gender, rare disease, IMP with orphan designation in the indication and age ranges of in-utero, adult or elderly do not apply to these records.
    1  2  Next»
    Study title: NO PAEDS INFO Strabismus surgery in children (in German)
    Active substance: ATROPINE
    Study summary document link (including results): NO PAEDS INFO Strabismus surgery in children (in German).pdf
    View full study record
    Document reference: 47089
    Study title: Zak-T-A, D-Ambrosio-F-A-Jr. Nutritional nystagmus in infants. Journal of pediatric ophthalmology and strabismus, {J-Pediatr-Ophthalmol-Strabismus}, Jul-Aug 1985, vol. 22, no. 4, p. 140-2, ISSN: 0191-3913.Zak-T-A, D-Ambrosio-F-A-Jr. Nutritional nystagmus in infants. Journal of pediatric ophthalmology and strabismus, {J-Pediatr-Ophthalmol-Strabismus}, Jul-Aug 1985, vol. 22, no. 4, p. 140-2, ISSN: 0191-3913.
    Active substance: BIOTIN
    Study summary document link (including results):
    View full study record
    Document reference: 22647
    Study title: Dimenhydrinate decreases vomiting after strabismus surgery in children, Vener, D.F., Anesth. Analg. 1996; 82(4): 728-731Dimenhydrinate decreases vomiting after strabismus surgery in children, Vener, D.F., Anesth. Analg. 1996; 82(4): 728-731
    Active substance: CAFFEINE AND DIMENHYDRINATE
    Study summary document link (including results):
    View full study record
    Document reference: 23129
    Study title: Prophylaxis of postoperative nausea and vomiting (PONV) in children undergoing strabismus surgery. Sevoflurane/N2O plus dimenhydrinate vs. Propofol/remifentanil plus dimenhydrinate, Biallas, R., Anaestesist. 2003; 52(7): 586-595Prophylaxis of postoperative nausea and vomiting (PONV) in children undergoing strabismus surgery. Sevoflurane/N2O plus dimenhydrinate vs. Propofol/remifentanil plus dimenhydrinate, Biallas, R., Anaestesist. 2003; 52(7): 586-595
    Active substance: CAFFEINE AND DIMENHYDRINATE
    Study summary document link (including results):
    View full study record
    Document reference: 23103
    Study title: Rectally administered dimenhydrinate reduces postoperative vomiting in children after strabismus surgery, Schlager, A., Br. J. Anaesth. 2000; 84: 405-406Rectally administered dimenhydrinate reduces postoperative vomiting in children after strabismus surgery, Schlager, A., Br. J. Anaesth. 2000; 84: 405-406
    Active substance: CAFFEINE AND DIMENHYDRINATE
    Study summary document link (including results):
    View full study record
    Document reference: 23124
    Study title: Reduction of postoperative nausea and vomiting by dimenhydrinate suppositories after strabismus surgery in children, Welters, I.D., Anesth. Analg. 2000; 90: 311-314Reduction of postoperative nausea and vomiting by dimenhydrinate suppositories after strabismus surgery in children, Welters, I.D., Anesth. Analg. 2000; 90: 311-314
    Active substance: CAFFEINE AND DIMENHYDRINATE
    Study summary document link (including results):
    View full study record
    Document reference: 23131
    Study title: Postoperative emesis after pediatric strabismus surgery : the effect of dixyrazine compared to droperidol
    Active substance: DIXYRAZINE
    Study summary document link (including results):
    View full study record
    Document reference: 26277
    Study title: Dolasetron for the prevention of postoperative vomiting in children undergoing strabismus surgery. Paediatric Anaesthesia. 2003;13:522-526 - Wagner - 2003 - Publication in the GPE report reference Dolasetron mesilate-safety review_Sept96-Jan06_02 (appendix 5)
    Active substance: DOLASETRON
    Study summary document link (including results):
    View full study record
    Document reference: 26295
    Study title: Comparison of the efficacy of diclofenac and betamethasone following strabismus surgery. Wright M, Butt Z, McIlwaine G, Fleck B. Br J Ophthalmol. 1997 Apr;81(4):299-301. Comparison of the efficacy of diclofenac and betamethasone following strabismus surgery. Wright M, Butt Z, McIlwaine G, Fleck B. Br J Ophthalmol. 1997 Apr;81(4):299-301.
    Active substance: DICLOPHENAC AND TOBRAMYCIN
    Study summary document link (including results):
    View full study record
    Document reference: 26090
    Study title: Wennström B, Reinsfelt B. Rectally administered diclofenac (Voltaren) reduces vomiting compared with opioid (morphine) after strabismus surgery in children. Acta Anaesthesiol Scand. 2002 Apr;46(4):430-4.Wennström B, Reinsfelt B. Rectally administered diclofenac (Voltaren) reduces vomiting compared with opioid (morphine) after strabismus surgery in children. Acta Anaesthesiol Scand. 2002 Apr;46(4):430-4.
    Active substance: DICLOFENAC
    Study summary document link (including results):
    View full study record
    Document reference: 25974
    Study title: Efficacy of diclofenac versus dexamethasone for treatment after strabismus surgery. Snir M, Axer-Siegel R, Friling R, Weinberger D. Ophthalmology. 2000 Oct;107(10):1884-8.Efficacy of diclofenac versus dexamethasone for treatment after strabismus surgery. Snir M, Axer-Siegel R, Friling R, Weinberger D. Ophthalmology. 2000 Oct;107(10):1884-8.
    Active substance: CHLORAMPHENICOL_ CHLORAMPHENICOL +CORTISONE ACETATE +ETHACRIDINE LACTATE +ZINC OXIDE / CHLORAMPHENICOL AND MEDROXYPROGESTERONE AND TETRYZOLINE
    Study summary document link (including results): Efficacy of diclofenac vs dexamethasone.pdf
    View full study record
    Document reference: 23872
    Study title: A comparison of the pupillary and cardiovascular effects of various mydriatic agents in preterm infants.Sindel BD, Baker MD, Maisels MJ, Weinstein J. J Pediatr Ophthalmol Strabismus. 1986 Nov-Dec;23(6):273-6. A comparison of the pupillary and cardiovascular effects of various mydriatic agents in preterm infants.Sindel BD, Baker MD, Maisels MJ, Weinstein J. J Pediatr Ophthalmol Strabismus. 1986 Nov-Dec;23(6):273-6.
    Active substance: CYCLOPENTOLATE
    Study summary document link (including results): A comparison of the pupillary and cardiovascular effects of .pdf
    View full study record
    Document reference: 24709
    Study title: A mydriatic eye-drop combination without systemic effects for premature infants: a prospective double-blind study.Bolt B, Benz B, Koerner F, Bossi E. J Pediatr Ophthalmol Strabismus. 1992 May-Jun;29(3):157-62. A mydriatic eye-drop combination without systemic effects for premature infants: a prospective double-blind study.Bolt B, Benz B, Koerner F, Bossi E. J Pediatr Ophthalmol Strabismus. 1992 May-Jun;29(3):157-62.
    Active substance: CYCLOPENTOLATE
    Study summary document link (including results): A mydriatic eye-drop combination without systemc effects for.pdf
    View full study record
    Document reference: 24702
    Study title: Comparison of mydriatic regimens used in screening for retinopathy of prematurity in preterm infants with dark irides.Chew C, Rahman RA, Shafie SM, Mohamad Z. J Pediatr Ophthalmol Strabismus. 2005 May-Jun;42(3):166-73. Comparison of mydriatic regimens used in screening for retinopathy of prematurity in preterm infants with dark irides.Chew C, Rahman RA, Shafie SM, Mohamad Z. J Pediatr Ophthalmol Strabismus. 2005 May-Jun;42(3):166-73.
    Active substance: CYCLOPENTOLATE
    Study summary document link (including results): Comparison of mydriatic regimens used in screening for retin.pdf
    View full study record
    Document reference: 24698
    Study title: Systemic response to mydriatic eyedrops in neonates: mydriatics in neonates.Caputo AR, Schnitzer RE. J Pediatr Ophthalmol Strabismus. 1978 Mar-Apr;15(2):109-22.Systemic response to mydriatic eyedrops in neonates: mydriatics in neonates.Caputo AR, Schnitzer RE. J Pediatr Ophthalmol Strabismus. 1978 Mar-Apr;15(2):109-22.
    Active substance: CYCLOPENTOLATE
    Study summary document link (including results): Systemic response to mydriatic eyedrops in neonates.pdf
    View full study record
    Document reference: 24712
    Study title: Efficacy of diclofenac versus dexamethasone for treatment after strabismus surgery.Snir M, Axer-Siegel R, Friling R, Weinberger D. Ophthalmology. 2000 Oct;107(10):1884-8. Efficacy of diclofenac versus dexamethasone for treatment after strabismus surgery.Snir M, Axer-Siegel R, Friling R, Weinberger D. Ophthalmology. 2000 Oct;107(10):1884-8.
    Active substance: DEXAMETHASONE NEOMYCIN POLYMYXIN B
    Study summary document link (including results):
    View full study record
    Document reference: 25757
    Study title: Efficacy of diclofenac versus dexamethasone for treatment after strabismus surgery.Snir M, Axer-Siegel R, Friling R, Weinberger D. Ophthalmology. 2000 Oct;107(10):1884-8.
    Active substance: DEXAMETHASONE_OR_DEXAMETHASONE AND CHLORAMPHENICOL
    Study summary document link (including results):
    View full study record
    Document reference: 25768
    Study title: Efficacy of diclofenac versus dexamethasone for treatment after strabismus surgery.Snir M, Axer-Siegel R, Friling R, Weinberger D. Ophthalmology. 2000 Oct;107(10):1884-8. 4. Postoperative miotics for patients with infantile esotropia.Spierer A, Zeeli T. Ophthalmic Surg Lasers. 1997 Dec;28(12):1002-5. Efficacy of diclofenac versus dexamethasone for treatment after strabismus surgery.Snir M, Axer-Siegel R, Friling R, Weinberger D. Ophthalmology. 2000 Oct;107(10):1884-8. 4. Postoperative miotics for patients with infantile esotropia.Spierer A, Zeeli T. Ophthalmic Surg Lasers. 1997 Dec;28(12):1002-5.
    Active substance: DEXAMETHASONE AND GENTAMYCIN AND TETRYZOLINE
    Study summary document link (including results):
    View full study record
    Document reference: 25736
    Study title: Efficacy of diclofenac versus dexamethasone for treatment after strabismus surgery.Snir M, Axer-Siegel R, Friling R, Weinberger D. Ophthalmology. 2000 Oct;107(10):1884-8. Efficacy of diclofenac versus dexamethasone for treatment after strabismus surgery.Snir M, Axer-Siegel R, Friling R, Weinberger D. Ophthalmology. 2000 Oct;107(10):1884-8.
    Active substance: DEXAMETHASONE AND NEOMYCIN
    Study summary document link (including results):
    View full study record
    Document reference: 25743
    Study title: Diclofenac vs oxybuprocaine eyedrops for analgesia in paediatric strabismus surgery. Morton NS, Benham SW, Lawson RA, McNicol LR. Paediatr Anaesth. 1997;7(3):221-6.
    Active substance: FLUORESCEIN AND OXYBUPRICAINE
    Study summary document link (including results):
    View full study record
    Document reference: 28249
    1  2  Next»
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Mon Jun 16 03:05:35 CEST 2025 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA